December 15, 2016 07:01 AM ESTUpdated 10:12 AM

Lonza bags Capsugel and its oral drug delivery tech for $5.5B: Biotech vet Truex named COO at Synlogic

Shehla Shakoor

Managing Director

Switzerland’s Lonza has bagged Morristown, NJ-based Capsugel for $5.5 billion in a deal designed to make the pharma industry supplier a world leader in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lonza bags Capsugel and its oral drug delivery tech for $5.5B: Biotech vet Truex named COO at Synlogic

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Are programs with compounded GLP-1s safe for your population?

Lon­za bags Cap­sug­el and its oral drug de­liv­ery tech for $5.5B: Biotech vet Truex named COO at Syn­log­ic

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Lonza bags Capsugel and its oral drug delivery tech for $5.5B: Biotech vet Truex named COO at Synlogic

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Are programs with compounded GLP-1s safe for your population?